Heterozygous germline FLCN mutation in Birt–Hogg–Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report

Journal of cancer research and clinical oncology(2022)

Cited 1|Views6
No score
Abstract
Background Birt–Hogg–Dubé (BHD) syndrome is a rare autosomal dominant tumor syndrome caused by Folliculin ( FLCN ) gene mutation. The clinical manifestations are diverse, and the renal tumor is the most serious. Case presentation We report the case of a 51-year-old female with multiple space-occupying lesions in both kidneys, as well as bilateral renal cysts and multiple lung cysts. The resected tumors were finally diagnosed as bilateral renal hybrid oncocytic/chromophobe tumor (HOCT) and unilateral chromophobe cell carcinoma. A history of pneumothorax surgery 4 years ago was convinced. All of these strongly suggested the possibility of BHD syndrome. Gene test confirmed a heterozygous germline FLCN nonsense mutation (c.1429C > T, p.Arg477Ter). The patient is still doing well after 20 months of follow-up (cut-off date July 2022). Conclusion This is a case of BHD syndrome presented with bilateral renal tumor, renal cysts, and multiple lung cysts, and confirmed by gene testing. Patients with any combination of one or more of the manifestations should remain alert to the BHD syndrome. Our report will help to deepen the understanding of the clinicopathological features and molecular changes of BHD syndrome.
More
Translated text
Key words
Birt–Hogg–Dubé syndrome,Chromophobe renal cell carcinoma,FLCN,Pulmonary cyst,Renal hybrid oncocytic/chromophobe tumor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined